SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001213900-19-008651
Filing Date
2019-05-15
Accepted
2019-05-15 06:10:02
Documents
5
Effectiveness Date
2019-05-15

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT fs82019_relmadatherapeutics.htm S-8 64377
2 OPINION OF FENNEMORE CRAIG, P.C. fs82019ex5-1_relmada.htm EX-5.1 7794
3 CONSENT OF MARCUM LLP fs82019ex23-1_relmada.htm EX-23.1 1930
4 CONSENT OF GBH CPAS, PC fs82019ex23-2_relmada.htm EX-23.2 2053
5 GRAPHIC image_001.jpg GRAPHIC 4035
  Complete submission text file 0001213900-19-008651.txt   82926
Mailing Address 750 THIRD AVENUE, 9TH FLOOR NEW YORK NY 10017
Business Address 750 THIRD AVENUE, 9TH FLOOR NEW YORK NY 10017 212-547-9591
RELMADA THERAPEUTICS, INC. (Filer) CIK: 0001553643 (see all company filings)

IRS No.: 455401931 | State of Incorp.: NV | Fiscal Year End: 0630
Type: S-8 | Act: 33 | File No.: 333-231477 | Film No.: 19824906
SIC: 2834 Pharmaceutical Preparations